Zymeworks Inc. (ZYME) reported $128.1M in cash spent on share repurchases for the period ended Jun 30, 2026, per its 10-Q filing with the SEC. The prior reported period (ended Mar 31, 2026, 10-Q) showed $76.15M.
Look up ZYME live in the tracker
Reported buybacks by filing period
| Period ended | Reported repurchases | Filing |
|---|---|---|
| Jun 30, 2026 | $128.1M | 10-Q 2026 Q2 |
| Mar 31, 2026 | $76.15M | 10-Q 2026 Q1 |
| Dec 31, 2025 | $41.7M | 10-K 2025 FY |
| Sep 30, 2025 | $16.22M | 10-Q 2025 Q3 |
| Dec 31, 2024 | $30.05M | 10-K 2024 FY |
| Sep 30, 2024 | $20.62M | 10-Q 2024 Q3 |
What this does and does not show
This is the cash a company says it spent buying back its own shares, exactly as filed under SEC XBRL concept PaymentsForRepurchaseOfCommonStock for each period end date. Depending on the filing, that figure covers a single quarter (10-Q) or a full fiscal year (10-K), compare the filing type before comparing dollar amounts across periods. This is not a trade-by-trade execution record and not a forecast of future buybacks. Run ZYME through the workspace to compare recent trading volume against reported activity.
Source
Put the explanation to work.
Change the assumptions, compare the results, and export the numbers without creating an account.
Open BuybackLedger